ENVISION: Increasing diversity of a large phase 3b/4 confirmatory trial of aducanumab to better understand the efficacy and safety among historically underrepresented participants of Alzheimer's disease research and clinical trials.

Authors: Montenigro, Philip H., Cheng, Wenting, O'Gorman, John, Murphy, Jennifer, Gillis, Cai, Maserejian, Nancy Nairi, Mascherino, Liz, Butts, Cherie, Ashraf, Daanish, Racine, Annie M, Aisen, Paul, Castrillo‐Viguera, Carmen, Haeberlein, Samantha Budd

Source: Alzheimer's & dementia. 18(10)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177000544.0x000001&indx=1&recIds=ETOCvdc_100177000544.0x000001